ABCD Webinar: History and management of diabetic ketoacidosis
In the first of our 2022 ABCD webinar series, which run on the first Thursday of the month, please join Professor Ketan Dhatariya to discuss the history and management of ketoacidosis.
Prior to the discovery of insulin, type 1 diabetes was universally fatal within a few months. Insulin revolutionised the world of diabetes. However, it took a long time to understand how insulin should be used, and at what doses. Of course the manufacturing process has also progressed to enable the use of human and then analogue insulins. This talk will go through the early studies on the management of DKA and how the use of hundreds, or even thousands of units given intramuscularly was common place. Then, in the 1970’s, seminal papers showed that low dose intravenous insulin was just as good in lowering glucose and ketone concentrations. The slow, and gentle evolutions have led to the current guidelines.
There remain many areas of uncertainty – the US and the UK guidelines differ – and it may be argued that the ADA guidelines are no longer fit for purpose. There are few studies ongoing to help inform clinical practice. However, with the availability of IT and large data gathering capability, there is new hope that evidence will inform the next versions of the guidelines rather than expert opinion. The outlook for the management of DKA looks good.
Q & A will follow this presentation
Accreditation for this meeting has been sought from the RCP London. Certificates of attendance will be emailed to you after the event.
He has several national roles in the UK. He is currently the Chair of the Joint British Diabetes Societies Inpatient Care Group where he has led or co-authored several national guidelines on the management of various aspects of inpatient diabetes care including the guideline on peri-operative diabetes care. He is the Chair of the Examining Board for the UK Specialist Clinical Exam in Diabetes and Endocrinology, as well as Chair of the newly developed European Board Examination in Endocrinology, Diabetes and Metabolism. He is the President of the Diabetes and Endocrine section of the Royal Society of Medicine. He is an Associate Editor of Diabetic Medicine and BMJ Open Diabetes Research & Care.
Dr Dhatariya has over 130 peer reviewed publications, over 100 abstracts, and has published several book chapters on inpatient diabetes, peri-operative diabetes care or on the diabetic foot. He was awarded a PhD on inpatient diabetes in 2017 by the University of East Anglia.
You can find more by visiting www.norfolkdiabetes.com
Outwith diabetes, he leads the South East Scotland thyroid cancer and neuroendocrine cancer services. He is Treasurer of the British Thyroid Foundation and a Trustee and Founder of the Ann Edgar Charitable Trust for patients with neuroendocrine cancers.
He is Secretary of the Royal College of Physicians of Edinburgh and former President of the Scottish Society of Physicians. He is an editor of the international textbook ‘Davidson’s Principles and Practice of Medicine.’
